GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.

Type 2 diabetes (T2D) has become one of the leading chronic diseases worldwide in terms of both incidence and mortality.

T2D increases the risk of several diseases, including cardiovascular disease and stroke, and is the leading cause of disability and death worldwide. Fortunately, T2D is preventable.

Vishay’s single-line VGSOTxx and two-line VGSOTxxC ESD protection diodes offer reverse working voltages from 3.3 V to 36 V. Compared to earlier GSOTxx/xxC devices, the automotive-grade diodes provide ...

TOPLINE: In patients with type 2 diabetes (T2D), treatment with oral semaglutide demonstrated a modest but significant reduction in serum urate levels, with substantially greater reductions ...

There is a low but increased risk of optic nerve disorders in patients with type 2 diabetes prescribed semaglutide or tirzepatide, according to a large cohort study.

In β-cells from people with T2D, however, this traffic is poorly managed. Fewer GLUTs reach the membrane, and their cycling is impaired, slowing down glucose entry.

New IISc study reveals potential breakthrough in diabetes treatment by targeting glucose uptake in pancreatic β-cells.

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and peripheral artery disease (PAD), potentially adding yet another ...

Nearly every TV on the market today is either OLED or LCD. Here's a look at the pros and cons of each technology.

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...